| http://www.w3.org/ns/prov#value | - Data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics for HIV/AIDS, monogenic diseases such as hemophilia, hemoglobinopathies and Huntington's disease as well as adoptive T-cell therapies for oncology were described in presentations given by Sangamo scientists and collaborators at the 15th Annual Meeting of the American Society of Gene and Cell
|
